272 related articles for article (PubMed ID: 32204464)
1. Cloning, Prokaryotic Soluble Expression, and Analysis of Antiviral Activity of Two Novel Feline IFN-ω Proteins.
Wang X; Li F; Han M; Jia S; Wang L; Qiao X; Jiang Y; Cui W; Tang L; Li Y; Xu YG
Viruses; 2020 Mar; 12(3):. PubMed ID: 32204464
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of a novel feline IFN-omega.
Yang LM; Xue QH; Sun L; Zhu YP; Liu WJ
J Interferon Cytokine Res; 2007 Feb; 27(2):119-27. PubMed ID: 17316139
[TBL] [Abstract][Full Text] [Related]
3. Cloning and codon optimization of a novel feline interferon omega gene for production by
Wang Y; Jiang S; Jiang X; Sun X; Guan X; Han Y; Zhong L; Song H; Xu Y
Virulence; 2022 Dec; 13(1):297-309. PubMed ID: 35068319
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of antiviral activity between FeIFN-omega and FeIFN-alpha].
Wang H; Jia X; Yang L; Sun L; Wang H; Liu W
Sheng Wu Gong Cheng Xue Bao; 2008 Sep; 24(9):1556-60. PubMed ID: 19160837
[TBL] [Abstract][Full Text] [Related]
5. Cloning, expression, purification, and biological activity of five feline type I interferons.
Wonderling R; Powell T; Baldwin S; Morales T; Snyder S; Keiser K; Hunter S; Best E; McDermott MJ; Milhausen M
Vet Immunol Immunopathol; 2002 Oct; 89(1-2):13-27. PubMed ID: 12208047
[TBL] [Abstract][Full Text] [Related]
6. Amino acid differences in interferon-tau (IFN-τ) of Bos taurus Coreanae and Holstein.
Kang D; Ryoo S; Chung B; Lee J; Park S; Han J; Jeong S; Rho G; Hong J; Bae S; Kang T; Kim S; Kim S
Cytokine; 2012 Aug; 59(2):273-9. PubMed ID: 22578803
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of feline type I interferon receptor 2.
Xue Q; Yang L; Liu X; Liu W
J Interferon Cytokine Res; 2010 Feb; 30(2):81-8. PubMed ID: 20028200
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses.
Buckwold VE; Wei J; Huang Z; Huang C; Nalca A; Wells J; Russell J; Collins B; Ptak R; Lang W; Scribner C; Blanchett D; Alessi T; Langecker P
Antiviral Res; 2007 Feb; 73(2):118-25. PubMed ID: 16987555
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of antiviral activities of porcine interferon type I and type II].
Chen X; Xue Q; Zhu R; Fu X; Yang L; Sun L; Liu W
Sheng Wu Gong Cheng Xue Bao; 2009 Jun; 25(6):806-12. PubMed ID: 19777805
[TBL] [Abstract][Full Text] [Related]
10. Effect of feline interferon-omega on the survival time and quality of life of cats with feline infectious peritonitis.
Ritz S; Egberink H; Hartmann K
J Vet Intern Med; 2007; 21(6):1193-7. PubMed ID: 18196725
[TBL] [Abstract][Full Text] [Related]
11. Preparation of CHO cell-derived rhIFN-ω-Fc with improved pharmacokinetics.
Li J; Li B; Zhang J; Hou L; Yu C; Fu L; Song X; Yu T; Zhang J; Ren J; Xu C; Chen W
Antiviral Res; 2011 Mar; 89(3):199-203. PubMed ID: 21277904
[TBL] [Abstract][Full Text] [Related]
12. Differential expression and activity of the porcine type I interferon family.
Sang Y; Rowland RR; Hesse RA; Blecha F
Physiol Genomics; 2010 Jul; 42(2):248-58. PubMed ID: 20406849
[TBL] [Abstract][Full Text] [Related]
13. Expression of feline interferon-alpha subtypes in Esherichia coli, and their antiviral activity and animal species specificity.
Taira O; Suzuki M; Takeuchi Y; Aramaki Y; Sakurai I; Watanabe T; Motokawa K; Arai S; Sato H; Maehara N
J Vet Med Sci; 2005 May; 67(5):543-5. PubMed ID: 15942143
[TBL] [Abstract][Full Text] [Related]
14. The biological effects of five feline IFN-alpha subtypes.
Baldwin SL; Powell TD; Sellins KS; Radecki SV; Cohen JJ; Milhausen MJ
Vet Immunol Immunopathol; 2004 Jun; 99(3-4):153-67. PubMed ID: 15135982
[TBL] [Abstract][Full Text] [Related]
15. Short communication: antiviral activity of porcine IFN-λ3 against porcine epidemic diarrhea virus in vitro.
Shen H; Zhang C; Guo P; Liu Z; Sun M; Sun J; Li L; Dong J; Zhang J
Virus Genes; 2016 Dec; 52(6):877-882. PubMed ID: 27470155
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of porcine interferon omega 7 against foot-and-mouth disease virus in vitro.
Li SF; Zhao FR; Gong MJ; Shao JJ; Xie YL; Chang HY; Zhang YG
J Med Virol; 2019 Feb; 91(2):208-214. PubMed ID: 30039874
[TBL] [Abstract][Full Text] [Related]
17. Homogeneous production of feline interferon in silkworm by replacing single amino acid code in signal peptide region in recombinant baculovirus and characterization of the product.
Ueda Y; Sakurai T; Yanai A
J Vet Med Sci; 1993 Apr; 55(2):251-8. PubMed ID: 7685640
[TBL] [Abstract][Full Text] [Related]
18. Interferon-omega: Current status in clinical applications.
Li SF; Zhao FR; Shao JJ; Xie YL; Chang HY; Zhang YG
Int Immunopharmacol; 2017 Nov; 52():253-260. PubMed ID: 28957693
[TBL] [Abstract][Full Text] [Related]
19. Vaccinia virus protein B18R inhibits the activity and cellular binding of the novel type interferon-delta.
Vancová I; La Bonnardiere C; Kontsek P
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1647-9. PubMed ID: 9680126
[TBL] [Abstract][Full Text] [Related]
20. A type I ovine interferon with limited similarity to IFN-alpha, IFN-omega and IFN-tau: gene structure, biological properties and unusual species specificity.
Liu L; Leaman DW; Bixby JA; Roberts RM
Biochim Biophys Acta; 1996 May; 1294(1):55-62. PubMed ID: 8639714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
